FR2318646A1 - Medicament injectable utilisable en anesthesie - Google Patents
Medicament injectable utilisable en anesthesieInfo
- Publication number
- FR2318646A1 FR2318646A1 FR7523269A FR7523269A FR2318646A1 FR 2318646 A1 FR2318646 A1 FR 2318646A1 FR 7523269 A FR7523269 A FR 7523269A FR 7523269 A FR7523269 A FR 7523269A FR 2318646 A1 FR2318646 A1 FR 2318646A1
- Authority
- FR
- France
- Prior art keywords
- hydroxy
- contg
- dioxolane
- dione
- dimethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003444 anaesthetic effect Effects 0.000 title abstract 2
- -1 hydroxy pregnane dione Chemical compound 0.000 title 1
- 238000001990 intravenous administration Methods 0.000 title 1
- 230000010412 perfusion Effects 0.000 title 1
- RNVYQYLELCKWAN-UHFFFAOYSA-N solketal Chemical compound CC1(C)OCC(CO)O1 RNVYQYLELCKWAN-UHFFFAOYSA-N 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- DUHUCHOQIDJXAT-OLVMNOGESA-N 3-hydroxy-(3-α,5-α)-Pregnane-11,20-dione Chemical compound C([C@@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)C)[C@@]2(C)CC1=O DUHUCHOQIDJXAT-OLVMNOGESA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- FYFFGSSZFBZTAH-UHFFFAOYSA-N methylaminomethanetriol Chemical compound CNC(O)(O)O FYFFGSSZFBZTAH-UHFFFAOYSA-N 0.000 abstract 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 239000008215 water for injection Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7523269A FR2318646A1 (fr) | 1975-07-25 | 1975-07-25 | Medicament injectable utilisable en anesthesie |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7523269A FR2318646A1 (fr) | 1975-07-25 | 1975-07-25 | Medicament injectable utilisable en anesthesie |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2318646A1 true FR2318646A1 (fr) | 1977-02-18 |
| FR2318646B1 FR2318646B1 (enExample) | 1978-10-06 |
Family
ID=9158363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7523269A Granted FR2318646A1 (fr) | 1975-07-25 | 1975-07-25 | Medicament injectable utilisable en anesthesie |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2318646A1 (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997007807A1 (en) * | 1995-08-23 | 1997-03-06 | Colin Stanley Goodchild | New use of pregnane-diones as analgesic agents |
| US6787530B1 (en) | 1996-08-23 | 2004-09-07 | Monash University | Use of pregnane-diones as analgesic agents |
-
1975
- 1975-07-25 FR FR7523269A patent/FR2318646A1/fr active Granted
Non-Patent Citations (1)
| Title |
|---|
| NEANT * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997007807A1 (en) * | 1995-08-23 | 1997-03-06 | Colin Stanley Goodchild | New use of pregnane-diones as analgesic agents |
| US6787530B1 (en) | 1996-08-23 | 2004-09-07 | Monash University | Use of pregnane-diones as analgesic agents |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2318646B1 (enExample) | 1978-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2000493A1 (en) | Blood perfusion system and tube means used therein | |
| Bedwani et al. | Enhanced inactivation of prostaglandin E2 by the rabbit lung during pregnancy or progesterone treatment | |
| KR890700349A (ko) | 피임 및 유방암 억제용 조성물 및 이의 제조방법 | |
| BEDFORD et al. | Studies on the biological disposition of griseofulvin, an oral antifungal agent | |
| FR2318646A1 (fr) | Medicament injectable utilisable en anesthesie | |
| GB1495289A (en) | Pharmaceutically active proteinaceous compounds | |
| Archer et al. | Bradykinin and eosinophils | |
| GB1355961A (en) | Preparation of immunosuppressive antilymphocytic serum | |
| Corrin et al. | Fine structure of an oat cell carcinoma of the lung associated with ectopic ACTH syndrome | |
| Musey et al. | Estriol metabolism in the baboon: Analysis of urinary and biliary metabolites | |
| Lucas et al. | Identification and purification of immunosuppressive activity in the urine of rats and a human patient treated with niridazole | |
| SU850082A1 (ru) | Способ лечени хронической экземы | |
| Estevez et al. | Enhancement of stimulant activity in rats chronically treated with cocaine. | |
| Müller et al. | Significance of Australia antigen in patients after kidney transplantation | |
| Long et al. | Experimental detection of left-to-right circulatory shunts with injections of krypton85 | |
| FR2226162A1 (en) | Oligosaccharide sulphuric acid ester - for treatment of arteriosclerosis | |
| Ozeki et al. | The effects of hydrocortisone and glycyrrhizine on the enzyme releases of arylsulfatase and hyaluronidase from lysosomes of liver | |
| Truelove | Treatment of ulcerative colitis with local hydrocortisone | |
| HIRANO et al. | Effect of ethanol on pancreatic lysosomes in rats: a possible mechanism for alcoholic pancreatitis | |
| Kuwajima | THE METABOLISM OF ELECTROLYTES IN JAPANESE B ENCEPHALITIS PART 1. QUANTITATIVE STUDY OF THE SERUM ELECTROLYTES IN MICE WITH EXPERIMENTAL JAPANESE B ENCEPHALITIS AND IN PATIENTS WITH THIS DISEASE | |
| Suzuki et al. | Mechanism of Action of Antibiotics. I Mode of Excretion and Accumulation of Aqueous Soluble and Basic Antibiotics in Mouse | |
| Thompson et al. | The chronic effects of nicotine monomethidide on gastric secretion in pylorus-ligated rats | |
| SU1676628A1 (ru) | Противоалкогольное средство "Гликал | |
| Larrey et al. | 160 PERIPHERAL BETA ENDORPHIN-LIKE IMMUNOREACTIVITY IN CIRRHOSIS WITH ASCITES. | |
| Stacy et al. | Induction of regression in the ovine corpus luteum by ICI 80,996, an analogue of prostaglandin F-2α |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |